A detailed history of Nuveen, LLC transactions in Neuro Pace Inc stock. As of the latest transaction made, Nuveen, LLC holds 18,420 shares of NPCE stock, worth $215,329. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,420
Holding current value
$215,329
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025

BUY
$10.04 - $14.94 $184,936 - $275,194
18,420 New
18,420 $226,000

Others Institutions Holding NPCE

About NeuroPace Inc


  • Ticker NPCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,846,900
  • Market Cap $290M
  • Description
  • NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...
More about NPCE
Track This Portfolio

Track Nuveen, LLC Portfolio

Follow Nuveen, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen, LLC with notifications on news.